Spasticity Management After Stroke
Spasticity Management After Stroke
复制标题
DOI：
10.1016/j.pmr.2015.07.003
复制
发表时间：
2015-11-01
影响因子：
1.7
通讯作者：
Bethoux, Francois
中科院分区：
文献类型：
--
作者：
Bethoux, Francois
许多中风后幸存者出现痉挛。痉挛通常与其他神经损伤有关，特别是轻瘫，这使得对其后果和治疗结果的评估变得复杂。痉挛的诊断和评估基于临床检查，特别是对被动运动的抵抗力和异常的不自主肌肉收缩。根据预先设定的目标，通常结合非药物治疗和药物治疗来控制痉挛。有证据支持大多数常用于治疗痉挛的药物的有效性和安全性；然而，需要更多关于功能结果和联合治疗方式的影响的证据。
Many poststroke survivors develop spasticity. Spasticity is usually associated with other neurologic impairments, in particular paresis, which complicate the evaluation of its consequences and of treatment outcomes. The diagnosis and the assessment of spasticity are based on clinical examination, in particular resistance to passive movement and abnormal involuntary muscle contraction. Nonpharmacologic and pharmacologic treatments are commonly combined to manage spasticity, based on prespecified goals. There is evidence supporting the effectiveness and safety of most medications commonly used to treat spasticity; however, more evidence is needed regarding functional outcomes and the impact of combining treatment modalities.